UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
MARK ONE
for the Quarterly Period ended
for the transition period from ________ to ________
ZION OIL & GAS, INC.
(Exact name of registrant as specified in its charter)
| | | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| | | |
| (Address of principal executive offices) | Zip Code |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| | ☐ | Smaller reporting company | |
| Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of May 5, 2025, Zion Oil & Gas, Inc. had outstanding
Consolidated Condensed Balance Sheets as of
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| US$ | US$ | |||||||
| thousands | thousands | |||||||
| (unaudited) | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Cash and cash equivalents – restricted | ||||||||
| Prepaid expenses and other | ||||||||
| Governmental receivables | ||||||||
| Other receivables | ||||||||
| Total current assets | ||||||||
| Unproved oil and gas properties, full cost method (see Note 4) | ||||||||
| Property and equipment at cost | ||||||||
| Drilling rig and related equipment, net of accumulated depreciation of $ and $ (see note 2I) | ||||||||
| Property and equipment, net of accumulated depreciation of $ and $ | ||||||||
| Right of Use Lease Assets (see Note 5) | ||||||||
| Other assets | ||||||||
| Assets held for severance benefits | ||||||||
| Total other assets | ||||||||
| Total assets | ||||||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable | ||||||||
| Insurance financing (see note 6D) | ||||||||
| Lease obligation – current (see Note 5) | ||||||||
| Asset retirement obligation | ||||||||
| Accrued liabilities | ||||||||
| Total current liabilities | ||||||||
| Long-term liabilities | ||||||||
| Lease obligation – non-current (see Note 5) | ||||||||
| Provision for severance pay | ||||||||
| Total long-term liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and contingencies (see Note 6) | ||||||||
| Stockholders’ equity | ||||||||
| Common stock, par value $; Authorized: shares at March 31, 2025: Issued and outstanding: and shares at March 31, 2025 and December 31, 2024, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Stock subscription receivable | ( | ) | ||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | ||||||||
The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Consolidated Condensed Statements of Operations (Unaudited)
| For the three months ended |
||||||||
| March 31, |
||||||||
| 2025 |
2024 |
|||||||
| US$ |
US$ |
|||||||
| thousands |
thousands |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| General and administrative |
||||||||
| Other |
||||||||
| Loss from operations |
( |
) | ( |
) | ||||
| Other income (expense), net |
||||||||
| Foreign exchange income |
||||||||
| Financial income (expenses), net |
( |
) | ||||||
| Loss, before income taxes |
( |
) | ( |
) | ||||
| Income taxes |
||||||||
| Net loss |
( |
) | ( |
) | ||||
| Net loss per share of common stock |
||||||||
| Basic and diluted (in US$) |
( |
) | ( |
) | ||||
| Weighted-average shares outstanding |
||||||||
| Basic and diluted (in thousands) |
||||||||
The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)
For the three months ended March 31, 2025
| Additional | ||||||||||||||||||||||||
| Common Stock | paid-in | Subscription | Accumulated | |||||||||||||||||||||
| Shares | Amounts | Capital | Receivable | deficit | Total | |||||||||||||||||||
| US$ | US$ | US$ | US$ | US$ | ||||||||||||||||||||
| thousands | thousands | thousands | thousands | thousands | thousands | |||||||||||||||||||
| Balances as of December 31, 2024 | ( | ) | ||||||||||||||||||||||
| Funds received from sale of DSPP units and shares and exercise of warrants | ( | ) | ||||||||||||||||||||||
| Funds received from option exercises | * | |||||||||||||||||||||||
| Value of options granted to employees, directors and others as non-cash compensation | — | |||||||||||||||||||||||
| Net loss | — | ( | ) | ( | ) | |||||||||||||||||||
| Balances as of March 31, 2025 | ( | ) | ( | ) | ||||||||||||||||||||
| * |
Less than one thousand. |
Zion Oil & Gas, Inc.
Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)
For the three months ended March 31, 2024
| Additional |
||||||||||||||||||||
| Common Stock |
paid-in |
Accumulated |
||||||||||||||||||
| Shares |
Amounts |
Capital |
deficit |
Total |
||||||||||||||||
| US$ |
US$ |
US$ |
US$ |
|||||||||||||||||
| thousands |
thousands |
thousands |
thousands |
thousands |
||||||||||||||||
| Balances as of December 31, 2023 |
( |
) | ||||||||||||||||||
| Funds received from sale of DSPP units and shares and exercise of warrants |
||||||||||||||||||||
| Funds received from option exercises |
||||||||||||||||||||
| Costs associated with the issuance of shares |
— | ( |
) | ( |
) | |||||||||||||||
| Value of options granted to employees, directors and others as non-cash compensation |
— | |||||||||||||||||||
| Net loss |
— | ( |
) | ( |
) | |||||||||||||||
| Balances as of March 31, 2024 |
( |
) | ||||||||||||||||||
The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Consolidated Condensed Statements of Cash Flows (Unaudited)
| For the Three Months Ended |
||||||||
| March 31, |
||||||||
| 2025 |
2024 |
|||||||
| US$ |
US$ |
|||||||
| thousands |
thousands |
|||||||
| (Unaudited) |
(Unaudited) |
|||||||
| Cash flows from operating activities |
||||||||
| Net loss |
( |
) | ( |
) | ||||
| Adjustments required to reconcile net loss to net cash used in operating activities: |
||||||||
| Depreciation |
||||||||
| Amortization of Right of Use Lease Assets |
||||||||
| Cost of options issued to employees, directors and others as non-cash compensation |
||||||||
| Change in assets and liabilities, net: |
||||||||
| Prepaid expenses and other |
( |
) | ||||||
| Governmental receivables |
( |
) | ( |
) | ||||
| Other receivables |
( |
) | ( |
) | ||||
| Lease obligation – current and non-current |
( |
) | ( |
) | ||||
| Provision for severance pay, net |
( |
) | ||||||
| Accounts payable |
( |
) | ( |
) | ||||
| Accrued liabilities |
( |
) | ( |
) | ||||
| Net cash used in operating activities |
( |
) | ( |
) | ||||
| Cash flows from investing activities |
||||||||
| Acquisition of property and equipment |
( |
) | ( |
) | ||||
| Acquisition of drilling rig and related equipment |
( |
) | ||||||
| Investment in unproved oil and gas properties |
( |
) | ( |
) | ||||
| Net cash used in investing activities |
( |
) | ( |
) | ||||
| Cash flows from financing activities |
||||||||
| Proceeds from exercise of stock options |
||||||||
| Costs paid related to the issuance of new shares |
( |
) | ||||||
| Proceeds from issuance of stock and exercise of warrants |
||||||||
| Net cash provided by financing activities |
||||||||
| Net increase in cash, cash equivalents and restricted cash |
||||||||
| Cash, cash equivalents and restricted cash – beginning of period |
||||||||
| Cash, cash equivalents and restricted cash – end of period |
||||||||
| Supplemental schedule of cash flow information |
||||||||
| Non-cash investing and financing activities: |
||||||||
| Unpaid investments in oil & gas properties |
||||||||
| Unpaid Costs associated with the issuance of shares |
||||||||
| Depreciation of oil and gas equipment |
||||||||
| Stock subscription receivable |
||||||||
| Addition of right of use lease assets and lease obligations |
||||||||
The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.
Cash, cash equivalents and restricted cash, are comprised as follows:
| March 31, |
December 31, |
|||||||
| 2025 |
2024 |
|||||||
| US$ |
US$ |
|||||||
| thousands |
thousands |
|||||||
| Cash and cash equivalents |
||||||||
| Cash and cash equivalents – restricted |
||||||||
Note 1 - Nature of Operations, Basis of Presentation and Going Concern
A. Nature of Operations
Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 25 years of oil & gas exploration in Israel. As of March 31, 2025, the Company has
Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.
On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.
On October 19, 2022, Zion incorporated a wholly owned subsidiary in Israel, Zion Drilling Israel Ltd, for the purpose of owning a drilling rig and related equipment and spare parts. On this date, the entity was created as a placeholder only. A bank account was created in November 2024 and a tax file was created in January 2025. The bank account is denominated in Israeli Shekels. When there will be bank transactions in the future, there will be a translation adjustment to United States Dollars. Zion Drilling Israel LTD did not have any activities during the three months ended March 31, 2025.
Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.
Exploration Rights/Exploration Activities
New Megiddo Valleys License 434 (“NMVL 434”) – Megiddo-Jezreel #1 Re-Entry (“MJ-01”)
On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately
On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee officially accepted our work plan for the MJ-01 re-completion project. This acceptance allowed us to sign agreements and secure mobilization dates with our service providers to commence and complete the project.
The initial phase of our recompletion project consisted of a category three inspection of the drilling rig, rigging down from MJ-02 and moving and rigging up over the MJ-01 well.
Stage two of the operation involved drilling out both the steel plugs along with 625 meters (about 2,050 feet) of cement plugs and re-conditioning the wellbore to allow unhindered access to the selected zones for testing.
After six years of inactivity in a well over three miles deep, the MJ-01 wellbore presents a challenging environment. The wellbore appears to have experienced elastic and partial collapse of the casing in some areas. This led to the bottom hole assembly (“BHA”) becoming stuck over 4,000 meters from surface. Attempts to overpull the BHA were unsuccessful, and the crew completed a backoff operation which left over 500 meters of the BHA remaining downhole. This is not an uncommon occurrence with oil and gas drilling operations and the crew was unsuccessful in retrieving the remaining BHA with the tools that were on location.
Another delay arose out of the logistical challenges we face. The ongoing conflict in the region has impacted shipping routes, the timely arrival of necessary equipment, and created travel difficulties for our rig crews. Our operations require specialized rig crews who are not available in Israel.
An even further delay was created by many of our rig crew members reaching the limit of their work visas. This requires us to reset visas, which is not a simple process, and it adds another layer of delay and complexity. Moreover, the recent changes to visa eligibility have further complicated the process, as Israel, in just the last few months, has changed their 90-day visa renewals from resetting at the end of the year to resetting after six months after expiration. We are working with the Ministry of Interior on this issue. As a side note, the crew had to enter Israel under 90-day visas and not six month or visas in order to comply with the labor law requirements in place at the time the operation commenced.
In light of the combination of downhole, logistical, and crew challenges, as well as holidays, and the one-year remembrance of October 7, we temporarily paused active operations during Q4 2024. This was a necessary step to ensure the safety of our personnel and to ensure proper engineering and tools are brought to location to avoid lengthy delays waiting for additional tools should any be required once the job resumes. With the necessary tools and renewed visas for our crews, we can resumed operations in Q1 2025. This is, of course, subject to the realities of the present geopolitical environment. The conflict in Israel, while not directly impacting our operations on a daily basis, creates uncertainties that could affect our schedule at any time.
Zion’s rig crew arrived in Israel in February 2025 and has completed critical maintenance and preparatory work. The rig, which was safely “warm stacked” in September 2024, underwent necessary checks for maintenance, including fluid changes, lubrication and greasing, and mechanical, electrical, and safety audits to ensure peak functionality. The rig crew drilled out the temporary plug at approximately 1,100 meters and set a permanent plug at the deeper part of the well, allowing for isolation of targeted zones for testing.
Perforation and stimulation operations were successfully completed, with gas observed at surface during early flowback. The well is currently in the fluid recovery and cleaning phase. Zion is sourcing additional equipment to continue flowback testing and conduct volumetric analysis to evaluate reservoir characteristics. These efforts are part of Zion’s ongoing plan to optimize recovery and assess the well’s production potential. Zion anticipates progressing through the well completion and testing operations during Q2 2025.
B. Basis of Presentation
The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of the operating results for the year ending December 31, 2025 or for any other subsequent interim period.
C. Going Concern
The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons.
The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be in doubt. The consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the three months ended March 31, 2025, the Company incurred a net loss of approximately $
To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 2 - Summary of Significant Accounting Policies
A. Net Loss per Share Data
Basic and diluted net loss per share of common stock, par value $
Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of
B. Use of Estimates
The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases, accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, political instability and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.
The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international markets. We have made estimates of the impact of COVID-19 within our consolidated financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. We have made the same estimates as to the potential impact the Israel-Hamas war, as well as the Israel- Hezbollah war, may have on our operations. Actual results may differ from these estimates.
C. Oil and Gas Properties and Impairment
The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.
All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.
The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.
During the three months ended March 31, 2025, and 2024, the Company did record any post-impairment charges.
Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $
D. Fair Value Measurements
The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.
The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:
| ● | Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; |
| ● | Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and |
| ● | Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. |
The Company’s financial instruments, including cash and cash equivalents, other receivables, prepaid expenses and other, Government receivables, accounts payable and accrued liabilities, are carried at historical cost. At March 31, 2025, and December 31, 2024, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.
E. Stock-Based Compensation
ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).
The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 718. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.
F. Warrants
In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.
G. Related parties
Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.
Zion did not have any related party transactions for the periods covered in this report.
H. Recently Adopted Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. The ASU improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments will be applied retrospectively to all prior periods presented in the financial statements. Zion adopted this ASU effective January 1, 2023. The adoption of this ASU did not have any impact on its consolidated financial statements.
Other Recent Accounting Pronouncements
The Company does not believe that the adoption of any recently issued accounting pronouncements in 2025 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.
I. Depreciation and Accounting for Drilling Rig and Related Equipment
Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $
Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.
It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.
Zion purchased rig spare parts and other drilling equipment totaling approximately $
See the table below for a reconciliation of the rig-related activity during the period ended March 31, 2025:
I-35 Drilling Rig & Associated Equipment:
| Three Months Ended March 31, 2025 | ||||||||||||||||
| I-35 | Rig | Other | ||||||||||||||
| Drilling | Spare | Drilling | ||||||||||||||
| Rig | Parts | Assets | Total | |||||||||||||
| US$ | US$ | US$ | US$ | |||||||||||||
| Gross Assets: | thousands | thousands | thousands | thousands | ||||||||||||
| December 31, 2024 | ||||||||||||||||
| Asset Additions | ||||||||||||||||
| Asset Disposals for Self-Consumption | ( | ) | ( | ) | ||||||||||||
| March 31, 2025 | ||||||||||||||||
| Accumulated Depreciation: | ||||||||||||||||
| December 31, 2024 | ||||||||||||||||
| Asset Depreciation | ||||||||||||||||
| March 31, 2025 | ||||||||||||||||
| Assets Net | ||||||||||||||||
| As of December 31, 2024 | ||||||||||||||||
| I-35 | Rig | Other | ||||||||||||||
| Drilling | Spare | Drilling | ||||||||||||||
| Rig | Parts | Assets | Total | |||||||||||||
| US$ | US$ | US$ | US$ | |||||||||||||
| Gross Assets: | thousands | thousands | thousands | thousands | ||||||||||||
| December 31, 2023 | ||||||||||||||||
| Asset Additions | ||||||||||||||||
| Asset Disposals | ( | ) | ( | ) | ||||||||||||
| Asset Disposals for Self-Consumption | ( | ) | ( | ) | ||||||||||||
| December 31, 2024 | ||||||||||||||||
| Accumulated Depreciation: | ||||||||||||||||
| December 31, 2023 | ||||||||||||||||
| Asset Depreciation | ||||||||||||||||
| December 31, 2024 | ||||||||||||||||
| Assets Net | ||||||||||||||||
Note 3 - Stockholders’ Equity
The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $
A. 2021 Omnibus Incentive Stock Option Plan
Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder
The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.
The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed years from the date of grant.
During the three months ended March 31, 2025, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase |
| ii. | Options to purchase |
During the three months ended March 31, 2024, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:
| i. | Options to purchase |
| ii. | Options to purchase |
B. Stock Options
The stock option transactions since January 1, 2025 are shown in the table below:
| Weighted | ||||||||
| Average | ||||||||
| Number of | exercise | |||||||
| shares | price | |||||||
| US$ | ||||||||
| Outstanding, December 31, 2024 | ||||||||
| Changes during 2025 to: | ||||||||
| Granted to employees, officers, directors and others | ||||||||
| Expired/Cancelled/Forfeited | ( | ) | ||||||
| Exercised | ( | ) | ||||||
| Outstanding, March 31, 2025 | ||||||||
| Exercisable, March 31, 2025 | ||||||||
The following table summarizes information about stock options outstanding as of March 31, 2025:
| Shares underlying outstanding options (non-vested) | Shares underlying outstanding options (fully vested) | ||||||||||||||||||||||||||||
| Weighted | Weighted | ||||||||||||||||||||||||||||
| average | Weighted | average | Weighted | ||||||||||||||||||||||||||
| Range of | remaining | Average | Range of | remaining | Average | ||||||||||||||||||||||||
| exercise | Number | contractual | Exercise | exercise | Number | contractual | Exercise | ||||||||||||||||||||||
| price | outstanding | life (years) | price | price | Outstanding | life (years) | price | ||||||||||||||||||||||
| US$ | US$ | US$ | US$ | ||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | |||||||||||||||||||||||||||||
| — | — | ||||||||||||||||||||||||||||
| 0.01-0.92 | |||||||||||||||||||||||||||||
Granted to employees
The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
| For the three months ended | ||||||||
| March 31, | ||||||||
| 2025 | 2024 | |||||||
| Weighted-average fair value of underlying stock at grant date | $ | $ | ||||||
| Dividend yields | — | — | ||||||
| Expected volatility | % | % | ||||||
| Risk-free interest rates | % | % | ||||||
| Expected lives (in years) | ||||||||
| Weighted-average grant date fair value | $ | $ | ||||||
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the options.
The expected life represents the weighted average period of time that options granted are expected to be outstanding. The expected life of the options granted to employees and directors is calculated based on the Simplified Method as allowed under Staff Accounting Bulletin No. 110 (“SAB 110”), giving consideration to the contractual term of the options and their vesting schedules, as the Company does not have sufficient historical exercise data at this time. The expected life of the option granted to non-employees equals their contractual term. In the case of an extension of the option life, the calculation was made on the basis of the extended life.
C. Compensation Cost for Warrant and Option Issuances
The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:
| For the Three Months Ended March 31, | |||||
| 2025 | 2024 | ||||
| US$ thousands | US$ thousands | ||||
The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:
| For the Three Months Ended March 31, | |||||
| 2025 | 2024 | ||||
| US$ thousands | US$ thousands | ||||
D. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)
On March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.
On December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January 8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
As of January 8, 2024, any outstanding ZNWAG warrants expired.
Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $
On March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (
On June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On December 18, 2023, the Company extended the termination date of the ZNWAM warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On March 28, 2024, the Company extended the termination date of the ZNWAM warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On January 21, 2025, the Company extended the termination date of the ZNWAM warrant from December 31, 2024 to March 31, 2025. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On March 18, 2025, the entire number of outstanding warrants of
Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase share of our Common Stock at a warrant exercise price of The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable through July 15, 2023 at a revised per share exercise price of
Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On August 21, 2023, the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On October 19, 2023, the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On December 18, 2023, the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On March 28, 2024, the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
On January 21, 2025, the Company extended the termination date of the ZNWAQ warrant from December 31, 2024 to March 31, 2025. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.
During March 2025, the entire number of outstanding warrants of
Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised per share exercise price of
Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of The warrant shall have the company notation of “ZNWAT.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of
Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of The warrant shall have the company notation of “ZNWAU.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of
Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Zion incurred $
On January 1, 2024, the Company executed a Waiver Term Sheet with a participant consisting of shares of stock. After conclusion of the program on March 31, 2024, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the three months ended March 31, 2024, Zion incurred $
During the three months ended March 31, 2025, Zion did not incur any equity issuance costs.
On April 1, 2024, the Company executed its current Waiver Term Sheet with a participant consisting of shares of stock and warrants.
The program was scheduled to terminate at the earlier of: (a) a maximum purchase of $
On or around August 13, 2024, a first amendment to its current Waiver Term Sheet was signed with the participant. The additional terms of the Waiver Term sheet included the pro-rata issuance of up to
On or around September 30, 2024, a second amendment to its current Waiver Term Sheet was signed with the participant. The additional terms of the Waiver Term sheet included changing the expiration date to December 31, 2024 and the pro-rata issuance of up to
On or around November 12, 2024, a third amendment to its current Waiver Term Sheet was signed with the participant. The additional terms of the Waiver Term sheet included changing the provision for the program termination provided that the closing stock price is cents per share or higher for five (5) consecutive days.
On or around January 21, 2025, a fourth amendment to this latest Waiver Term Sheet was signed with the participant. The Pricing Plan of the program terminates at the earlier of: (a) a maximum purchase of $
During 2025, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately
During 2024, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately
On March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December 15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock Purchase Plan. The Prospectus forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15, 2021.
Amendment No. 3 – New Unit Option under the Unit Program
Under our Plan, we provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.
Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 2. Amendment No. 3 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May 15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $
Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (
The ZNWAZ warrants became exercisable on July 17, 2023 and continued to be exercisable through July 17, 2024 at a per share exercise price of $
On July 17, 2024, any outstanding ZNWAZ warrants expired.
Amendment No. 4 – New Unit Option under the Unit Program
Under our Plan, we provided a Unit Option under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and was scheduled to terminate on December 31, 2023. See Amendment No. 5 below for data on an extension.
Our Unit Program consists of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 4 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option began on November 6, 2023 and terminated on December 31, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $
Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (
The ZNWBA warrants became exercisable on January 15, 2024, and continued to be exercisable through January 15, 2025, unless extended, at a per share exercise price of $
Amendment No. 5 – Extension of Termination Date to January 31, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on January 31, 2024.
The ZNWBA warrants now will be first exercisable on February 15, 2024, instead of January 15, 2024 and continued to be exercisable through February 15, 2025, instead of January 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 5 to Prospectus Supplement was December 20, 2023.
Amendment No. 6 – Extension of Termination Date to February 29, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on February 29, 2024.
The ZNWBA warrants now will be exercisable on March 15, 2024, instead of February 15, 2024 and continued to be exercisable through March 15, 2025, instead of February 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 6 to Prospectus Supplement was January 29, 2024.
Amendment No. 7 – Extension of Termination Date to March 31, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we are extending the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on March 31, 2024.
The ZNWBA warrants now will be first exercisable on April 15, 2024, instead of March 15, 2024 and continued to be exercisable through April 15, 2025, instead of March 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 7 to Prospectus Supplement was February 26, 2024.
Amendment No. 8 – Extension of Termination Date to April 30, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on April 30, 2024.
The ZNWBA warrants now will be first exercisable on May 15, 2024, instead of April 15, 2024, and continue to be exercisable through May 15, 2025, instead of April 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 8 to Prospectus Supplement was March 23, 2024.
Amendment No. 9 – Extension of Termination Date to May 31, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on May 31, 2024.
The ZNWBA warrants now will be first exercisable on June 15, 2024, instead of May 15, 2024, and continue to be exercisable through June 15, 2025, instead of May 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 9 to Prospectus Supplement was April 24, 2024.
Amendment No. 10 – Extension of Termination Date to August 31, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on August 31, 2024.
The ZNWBA warrants now will be first exercisable on September 15, 2024, instead of June 15, 2024, and continue to be exercisable through September 14, 2025, instead of June 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 10 to Prospectus Supplement was May 29, 2024.
Amendment No. 11 – Extension of Termination Date to October 15, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on October 15, 2024.
The ZNWBA warrants now will be first exercisable on November 15, 2024, instead of September 15, 2024, and continue to be exercisable through November 14, 2025, instead of September 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 11 to Prospectus Supplement was August 22, 2024.
Amendment No. 12 – Extension of Termination Date to December 31, 2024
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply. We extended under our Unit Program that was to terminate October 15, 2024, but now will terminate December 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.
For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (
The ZNWBA warrants will be first exercisable on January 31, 2025, instead of November 15, 2024, and continue to be exercisable through January 31, 2026, instead of November 15, 2025, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 12 to Prospectus Supplement was October 9, 2024.
Amendment No. 13 – Extension of Termination Date to February 28, 2025
Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023, to terminate on February 28, 2025.
The ZNWBA warrants now will be first exercisable on March 31, 2025, instead of January 31, 2025, and continue to be exercisable through March 31, 2026, instead of January 31, 2026, unless extended, at a per share exercise price of $
Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.
The date of this Amendment No. 13 to Prospectus Supplement was December 10, 2024.
The current Unit Option terminated on February 28, 2025 as described in Amendment No. 13. The ZWNBA warrants, exercisable at $
For the three months ended March 31, 2025, and 2024, approximately $
For the three months ended March 31, 2025, approximately $
For the three months ended March 31, 2024, approximately $
The company raised approximately $
The warrants represented by the company notation ZNWAA are tradeable on the OTCQB market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification and accounting purposes only.
E. Warrant Table
The warrant balances at December 31, 2024 and transactions since January 1, 2025 are shown in the table below:
| Warrant | Outstanding | Outstanding | |||||||||||||||||||||||
| Exercise | Termination | Balance, | Warrants | Warrants | Warrants | Balance, | |||||||||||||||||||
| Warrants | Price | Date | 12/31/2024 | Issued | Exercised | Expired | 03/31/2025 | ||||||||||||||||||
| ZNWAA | $ | 01/31/2026 | |||||||||||||||||||||||
| ZNWAM | $ | 03/31/2025 | ( | ) | |||||||||||||||||||||
| ZNWAQ | $ | 03/31/2025 | ( | ) | |||||||||||||||||||||
| ZNWBA | $ | 03/31/2026 | |||||||||||||||||||||||
| Outstanding warrants | ( | ) | |||||||||||||||||||||||
F. Warrant Descriptions of Current Warrants
The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with a future expiration date.
| Period of Grant | US$ | Expiration Date | |||||
| ZNWAA Warrants | A,B,C,D,H | March 2013 – December 2014 |
| ||||
| ZNWAS Warrants | E | August 2021 – March 2022 |
| ||||
| ZNWAT Warrants | E | August – September 2022 |
| ||||
| ZNWAU Warrants | E | October – November 2022 |
| ||||
| ZNWBA Warrants | F,G | November – December 2024 |
| ||||
| A | On May 29, 2019, the Company extended the expiration date of the Warrants by one ( |
|
| |
| B | On September 15, 2020, the Company extended the expiration date of the Warrants by two ( |
|
| |
| C | On December 14, 2022, the Company extended the expiration date of the Warrants by one ( |
|
| |
| D | On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one ( |
|
| |
| E | These warrants were issued on March 31, 2025, and become exercisable beginning on November 15, 2025 and expire on December 31, 2025. |
|
| |
| F | On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant. |
| G | On May 29, 2024, the Company filed Amendment No. 10 whereby the current unit option was extended to August 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On August 22, 2024, the Company filed Amendment No. 11 whereby the current unit option was extended to October 15, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On October 9, 2024, the Company filed Amendment No. 12 whereby the current unit option was extended to December 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended to January 31, 2026. On December 10, 2024, the Company filed Amendment No. 13 whereby the current unit option was extended to February 28, 2025, when the unit option ended, and the exercise date and termination date of the related ZNWBA warrants were also extended to March 31, 2026. |
| H | On November 12, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year. The new expiration date is January 31, 2026. |
Note 4 - Unproved Oil and Gas Properties, Full Cost Method
Unproved oil and gas properties, under the full cost method, are comprised as follows:
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| US$ | US$ | |||||||
| thousands | thousands | |||||||
| Excluded from amortization base: | ||||||||
| Drilling costs, and other operational related costs | ||||||||
| Capitalized salary costs | ||||||||
| Capitalized interest costs | ||||||||
| Legal and seismic costs, license fees and other preparation costs | ||||||||
| Other costs | ||||||||
During the three months ended March 31, 2025, and 2024, the Company did not record any post-impairment charges.
Changes in Unproved oil and gas properties during the three months ended March 31, 2025 and 2024 are as follows:
| For the three months ended | ||||||||
| March 31, | ||||||||
| 2025 | 2024 | |||||||
| US$ | US$ | |||||||
| thousands | thousands | |||||||
| Excluded from amortization base: | ||||||||
| Drilling costs, and other operational related costs | ||||||||
| Capitalized salary costs | ||||||||
| Legal and seismic costs, license fees and other preparation costs | ||||||||
| Inclusive of non-cash amounts of approximately $ |
|
|
Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.
Note 5 - Right of use lease assets and lease obligations
The Company is a lessee in several non-cancellable operating leases for transportation and office space.
The table below presents the operating lease assets and liabilities recognized on the balance sheet as of March 31, 2025 and December 31, 2024:
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| US$ | US$ | |||||||
| thousands | thousands | |||||||
| Operating lease assets | $ | $ | ||||||
| Operating lease liabilities: | ||||||||
| Current operating lease liabilities | $ | $ | ||||||
| Non-current operating lease liabilities | $ | $ | ||||||
| Total operating lease liabilities | $ | $ | ||||||
The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.
The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.
The Company’s field office in Caesarea, Israel is under lease for
The Company had an option to renew the lease for another years from February 1, 2024 to January 31, 2029, provided it was not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS
The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of March 31, 2025 are:
| March 31, | ||||
| 2025 | ||||
| Weighted average remaining lease term (years) | ||||
| Weighted average discount rate | % | |||
The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of March 31, 2025:
| US$ | ||||
| thousands | ||||
| 2025 | ||||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| 2029 | ||||
| Thereafter | ||||
| Total undiscounted future minimum lease payments | ||||
| Less: portion representing imputed interest | ( | ) | ||
| Total undiscounted future minimum lease payments | ||||
Operating lease costs were $
Cash paid for amounts included in the measurement of operating lease liabilities was $
Right-of-use assets obtained in exchange for new operating lease liabilities were and $
Note 6 - Commitments and Contingencies
A. Litigation
From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes.
The Company is not subject to any litigation at the present time.
B. Recent Market Conditions – Coronavirus, Israel-Hamas War, Israel-Hezbollah War and the Russia-Ukraine War
Coronavirus
During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.
Israel-Hamas War
On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. Israel and Gaza subsequently entered into a multi-phase ceasefire involving the cessation of battles in exchange for release of Israeli hostages and Palestinian prisoners, but hostilities resumed pending release of the remaining Israeli hostages.
There is uncertainty as to how long the war inside the Gaza strip will last. While we acknowledge that uncertainty, the Company is moving forward with its MJ-01 recompletion activities (see note 1 for details).
It is important to note that Zion’s license area is not located near any current combat zones.
Israel-Hezbollah War and Wider Hostilities
Immediately after the October 7, 2023 Hamas attack on Israel, the terrorist organization Hezbollah (in Lebanon) began launching daily rockets into Israel. Over the course of the next several months, both Hezbollah and Israel traded rocket fire into the other country, but without engaging in a full war. During Q3 2024, both sides increased the frequency and number of missiles fired. In September 2024, Israel began a ground invasion into Lebanon. On or around November 27, 2024, Israel and Hezbollah signed a ceasefire agreement. As of the date of this report, both sides are holding to its terms.
Russia-Ukraine War
Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the quarter ended March 31, 2025, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine may have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company and actions that may be taken by governmental authorities related to the war.
C. Environmental and Onshore Licensing Regulatory Matters
The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings.
The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.
As of March 31, 2025, and December 31, 2024, the Company accrued and for license regulatory matters.
D. Insurance Financing
Effective March 12, 2024, the Company renewed its rig insurance policy with total premiums, taxes and fees for approximately $
Effective November 18, 2024, the Company renewed its third party liability policy in Israel with total premiums, taxes and fees for approximately $
Effective December 3, 2024 the Company renewed its Control of well (“COW”) insurance policy in Israel with total premiums, taxes and fees for approximately $
Effective December 28, 2024, the Company renewed its D&O insurance policy with total premiums, taxes and fees for approximately $
Effective March 12, 2025, the Company renewed its rig insurance policy with total premiums, taxes and fees for approximately $
As of March 31, 2025 and December 31, 2024, the Company had contractual obligations to pay for various lines of insurance, including directors and officers, rig and third-party liability. The balances for insurance financing were $
E. Bank Guarantees
As of March 31, 2025, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $
F. Vendor Concentration
The Company’s financial instruments that are exposed to a concentration of credit risk are accounts payable. At March 31, 2025, there were suppliers that represent
G. Risks
Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.
Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2025 through March 31, 2025, the USD has fluctuated by approximately
Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2025, we had cash, cash equivalents, and restricted cash of approximately $
The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.
Note 7 - Subsequent Events
The Company has evaluated subsequent events through May 8, 2025, the date of filing of this Quarterly Report on Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements, other than the following:
(i) Approximately $
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND THE RELATED NOTES TO THOSE STATEMENTS INCLUDED IN THIS FORM 10-Q. SOME OF OUR DISCUSSION IS FORWARD-LOOKING AND INVOLVES RISKS AND UNCERTAINTIES. FOR INFORMATION REGARDING RISK FACTORS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS, REFER TO THE DISCUSSION OF RISK FACTORS IN THE “DESCRIPTION OF BUSINESS” SECTION OF OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED December 31, 2024, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
Forward-Looking Statements
Certain statements made in this discussion are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may materially differ from actual results.
Forward-looking statements can be identified by terminology such as “may”, “should”, “expects”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, or “continue” or the negative of these terms or other comparable terminology and include, without limitation, statements regarding:
| ● |
the Israel-Hamas war which began in October 2023 and its effect on our exploration program; |
| ● |
the Israel-Hezbollah war which began in 2024, along with wider regional hostilities towards Israel, and its effect on our exploration program; |
| ● |
the going concern qualification in our consolidated condensed financial statements; |
| ● |
our ability to obtain new license areas to continue our exploration program; |
| ● |
our liquidity and our ability to raise capital to finance our overall exploration and development activities within our license area; |
| ● |
our ability to continue meeting the requisite continued listing requirements by OTCQB; |
| ● |
interruptions, increased financial costs and other adverse impacts of the covid 19 coronavirus pandemic, the Israel-Hamas war, the Israel-Hezbollah war and the Russia-Ukraine war on the drilling and testing of our petroleum exploration program and our capital raising efforts; |
| ● |
our ability to explore for and develop natural gas and oil resources successfully and economically within a license area; |
| ● |
our ability to maintain the exploration license rights to continue our petroleum exploration program; |
| ● |
the availability of equipment, such as seismic equipment, drilling rigs, and production equipment as well as access to qualified personnel; |
| ● |
the impact of governmental regulations, permitting and other legal requirements in Israel relating to onshore exploratory drilling; |
| ● |
our estimates of the time frame within which future exploratory activities will be undertaken; |
| ● |
changes in our exploration plans and related budgets; |
| ● |
the quality of future license areas with regard to, among other things, the existence of reserves in economic quantities; |
| ● |
anticipated trends in our business; |
| ● |
our future results of operations; |
| ● |
our capital expenditure program; |
| ● |
future market conditions in the oil and gas industry |
| ● |
the demand for oil and natural gas, both locally in Israel and globally; and |
| ● |
the impact of fluctuating oil and gas prices on our exploration efforts |
All references in this Quarterly Report to the “Company”, “Zion”, “we”, “us”, or “our”, are to Zion Oil and Gas, Inc., a Delaware corporation, and its wholly-owned subsidiaries, Zion Drilling, Inc. and Zion Drilling Services, Inc. described below.
Current Exploration and Operation Efforts
Zion Oil and Gas, Inc., a Delaware corporation, is an oil and gas exploration company with a history of 25 years of oil and gas exploration in Israel. We were incorporated in Florida on April 6, 2000 and reincorporated in Delaware on July 9, 2003. We completed our initial public offering in January 2007. Our common stock, par value $0.01 per share (the “Common Stock”) currently trades on the OTCQB marketplace of OTC Markets, Inc. under the symbol “ZNOG” and our Common Stock warrant under the symbol “ZNOGW.” On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.
On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.
We continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential. As previously announced, Zion is deploying new technologies and stimulation methods for its current re-entry into the MJ-01 well with the objective of potentially unlocking hydrocarbon flows in several identified key zones.
On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee officially accepted our work plan for the MJ-01 re-completion project. This acceptance allowed us to sign agreements and secure mobilization dates with our service providers to commence and complete the project.
The initial phase of our recompletion project consisted of a category three inspection of the drilling rig, rigging down from MJ-02 and moving and rigging up over the MJ-01 well.
Stage two of the operation involved drilling out both the steel plugs along with 625 meters (about 2,050 feet) of cement plugs and re-conditioning the wellbore to allow unhindered access to the selected zones for testing.
After six years of inactivity in a well over three miles deep, the MJ-01 wellbore presented a challenging environment. The wellbore appears to have experienced elastic and partial collapse of the casing in some areas. This led to the bottom hole assembly (“BHA”) becoming stuck over 4,000 meters from surface. Attempts to overpull the BHA were unsuccessful, and the crew completed a backoff operation which left over 500 meters of the BHA remaining downhole. This is not an uncommon occurrence with oil and gas drilling operations, and the crew was unsuccessful in retrieving the remaining BHA with the tools that were on location.
Another delay arose out of the logistical challenges we face. The ongoing conflict in the region has impacted shipping routes, the timely arrival of necessary equipment, and created travel difficulties for our rig crews. Our operations require specialized rig crews who are not available in Israel.
An even further delay was created by many of our rig crew members reaching the limit of their work visas. This requires us to reset visas, which is not a simple process, and it adds another layer of delay and complexity. Moreover, the recent changes to visa eligibility have further complicated the process, as Israel, in just the last few months, has changed their 90-day visa renewals from resetting at the end of the year to resetting after six months after expiration. We are working with the Ministry of Interior on this issue. As a side note, the crew had to enter Israel under 90-day visas and not six month or visas in order to comply with the labor law requirements in place at the time the operation commenced.
In light of the combination of downhole, logistical, and crew challenges, as well as holidays, and the one-year remembrance of October 7, we temporarily paused active operations during Q4 2024. This was a necessary step to ensure the safety of our personnel and to ensure proper engineering and tools are brought to location to avoid lengthy delays waiting for additional tools should any be required once the job resumes. We anticipate that once we have the necessary tools and renewed visas for our crews, we can resume operations in Q1 2025. This is, of course, subject to the realities of the present geopolitical environment. The conflict in Israel, while not directly impacting our operations on a daily basis, creates uncertainties that could affect our schedule at any time.
Zion’s rig crew arrived in Israel in February 2025, and has completed critical maintenance and preparatory work. The rig, which was safely “warm stacked” in September 2024, underwent necessary checks for maintenance, including fluid changes, lubrication and greasing, and mechanical, electrical, and safety audits to ensure peak functionality. The rig crew drilled out the temporary plug at approximately 1,100 meters and set a permanent plug at the deeper part of the well, allowing for isolation of targeted zones for testing. Perforation and stimulation operations were successfully completed, with gas observed at surface during early flowback. The well is currently in the fluid recovery and cleaning phase. Zion is sourcing additional equipment to continue flowback testing and conduct volumetric analysis to evaluate reservoir characteristics. These efforts are part of Zion’s ongoing plan to optimize recovery and assess the well’s production potential. Zion anticipates progressing through the well completion and testing operations during Q2 2025.
While our MJ-01 re-completion project has faced a multitude of hurdles, including an active conflict, downhole issues and logistical challenges, we continue to move forward each time a safe opportunity permits continuation of operations. However, we will only move forward in coordination with Israeli authorities. We are actively monitoring the port situation to import the items needed to complete the current work program. We remain optimistic about making significant progress in the coming months.
I-35 Drilling Rig & Associated Equipment
| Three Months Ended March 31, 2025 |
||||||||||||||||
| I-35 |
Rig |
Other |
||||||||||||||
| Drilling |
Spare |
Drilling |
||||||||||||||
| Rig |
Parts |
Assets |
Total |
|||||||||||||
| US$ |
US$ |
US$ |
US$ |
|||||||||||||
| Gross Assets: |
thousands | thousands | thousands | thousands | ||||||||||||
| December 31, 2024 |
6,494 | 747 | 344 | 7,585 | ||||||||||||
| Asset Additions |
- | 22 | 84 | 106 | ||||||||||||
| Asset Disposals for Self-Consumption |
- | (9 | ) | - | (9 | ) | ||||||||||
| March 31, 2025 |
6,494 | 760 | 428 | 7,682 | ||||||||||||
| Accumulated Depreciation: |
||||||||||||||||
| December 31, 2024 |
2,538 | - | 269 | 2,807 | ||||||||||||
| Asset Depreciation |
159 | - | 24 | 183 | ||||||||||||
| March 31, 2025 |
2,697 | - | 293 | 2,990 | ||||||||||||
| Assets Net |
3,797 | 760 | 135 | 4,692 | ||||||||||||
| As of December 31, 2024 |
||||||||||||||||
| I-35 |
Rig |
Other |
||||||||||||||
| Drilling |
Spare |
Drilling |
||||||||||||||
| Rig |
Parts |
Assets |
Total |
|||||||||||||
| US$ |
US$ |
US$ |
US$ |
|||||||||||||
| Gross Assets: |
thousands | thousands | thousands | thousands | ||||||||||||
| December 31, 2023 |
6,494 | 608 | 442 | 7,544 | ||||||||||||
| Asset Additions |
- | 178 | - | 178 | ||||||||||||
| Asset Disposals |
- | - | (98 | ) | (98 | ) | ||||||||||
| Asset Disposals for Self-Consumption |
- | (39 | ) | - | (39 | ) | ||||||||||
| December 31, 2024 |
6,494 | 747 | 344 | 7,585 | ||||||||||||
| Accumulated Depreciation: |
||||||||||||||||
| December 31, 2023 |
1,904 | - | 130 | 2,034 | ||||||||||||
| Asset Depreciation |
634 | - | 139 | 773 | ||||||||||||
| December 31, 2024 |
2,538 | - | 269 | 2,807 | ||||||||||||
| Assets Net |
3,956 | 747 | 75 | 4,778 | ||||||||||||
Zion’s ability to fully undertake all of these aforementioned activities is subject to its raising the needed capital from its continuing offerings, of which no assurance can be provided.
Map 1. Zion’s New Megiddo License 434 as of March 31, 2025.
Onshore Licensing, Oil and Gas Exploration and Environmental Guidelines
The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental cleanup of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner, the Energy Ministry, and the Environmental Ministry in recent years as it pertains to oil and gas activities. Mention of these guidelines was included in previous Zion Oil & Gas filings.
We acknowledge that these new regulations are likely to increase the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that additional financial burdens could occur as a result of the Ministry requiring cash reserves that could otherwise be used for operational purposes.
Capital Resources Highlights
We need to raise significant funds to finance the continued exploration efforts and maintain orderly operations. To date, we have funded our operations through the issuance of our securities and convertible debt. We will need to continue to raise funds through the issuance of equity and/or debt securities (or securities convertible into or exchangeable for equity securities). No assurance can be provided that we will be successful in raising the needed capital on terms favorable to us (or at all).
The Dividend Reinvestment and Stock Purchase Plan
On March 13, 2014, Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.
On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.
Please see Footnote 3D (“Dividend Reinvestment and Stock Purchase Plan (“DSPP”)), which is a part of this Form 10-Q filing, for details about specific stock purchase and unit programs, dates, and filings during the years 2024 and 2025.
For the three months ended March 31, 2025 and 2024, approximately $6,040,000 and $3,557,000 were raised under the DSPP program, respectively. The Company did not pay any equity issuance costs for the three months ended March 31, 2025 resulting in net cash provided of $6,040,000. For the three months ended March 31, 2024, the Company paid equity issuance costs of $726,000, resulting in net cash provided of $2,831,000.
For the three months ended March 31, 2025, and 2024, approximately $212,000 and $nil were recorded under the Company’s Statement of Changes in Stockholders’ Equity as Subscriptions Receivables.
The warrants balances at December 31, 2024 and transactions since January 1, 2025 are shown in the table below:
| Warrant |
Outstanding |
Outstanding |
|||||||||||||||||||||||
| Exercise |
Termination |
Balance, |
Warrants |
Warrants |
Warrants |
Balance, |
|||||||||||||||||||
| Warrants |
Price |
Date |
12/31/2024 |
Issued |
Exercised |
Expired |
03/31/2025 |
||||||||||||||||||
| ZNWAA |
$ | 2.00 | 01/31/2026 |
1,498,804 | - | - | - | 1,498,804 | |||||||||||||||||
| ZNWAM |
$ | 0.05 | 03/31/2025 |
4,376,000 | - | (4,376,000 | ) | - | - | ||||||||||||||||
| ZNWAQ |
$ | 0.05 | 03/31/2025 |
23,428,348 | - | (23,428,348 | ) | - | - | ||||||||||||||||
| ZNWBA |
$ | 0.25 | 03/31/2026 |
- | 1,178,100 | - | - | 1,178,100 | |||||||||||||||||
| Outstanding warrants |
29,303,152 | 1,178,100 | (27,804,348 | ) | - | 2,676,904 | |||||||||||||||||||
Principal Components of our Cost Structure
Our operating and other expenses primarily consist of the following:
| ● |
Impairment of Unproved Oil and Gas Properties: Impairment expense is recognized if a determination is made that a well will not be commercially productive. The amounts include amounts paid in respect of the drilling operations as well as geological and geophysical costs and various amounts that were paid to Israeli regulatory authorities. |
| ● |
General and Administrative Expenses: Overhead, including payroll and benefits for our corporate staff, costs of managing our exploratory operations, audit and other professional fees, and legal compliance is included in general and administrative expenses. General and administrative expenses also include non-cash stock-based compensation expense, investor relations related expenses, lease and insurance and related expenses. |
| ● |
Depreciation, Depletion, Amortization and Accretion: The systematic expensing of the capital costs incurred to explore for natural gas and oil represents a principal component of our cost structure. As a full cost company, we capitalize all costs associated with our exploration, and apportion these costs to each unit of production, if any, through depreciation, depletion and amortization expense. As we have yet to have production, the costs of abandoned wells are written off immediately versus being included in this amortization pool. |
Going Concern Basis
Since we have limited capital resources, no revenue to date and a loss from operations, our consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The appropriateness of using the going concern basis is dependent upon our ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Israel-Hamas War
The nation of Israel declared war on Hamas following the October 7, 2023 invasion by Hamas into many southern Israeli communities, killing and injuring thousands and taking of over 200 Israeli hostages into Gaza. Israel formed a war time emergency government with its primary focus on defending its homeland. As part of the war effort, Israel activated a large number of reservists. Our geologist in Israel, Nadav Navon, was called into service for a month or two in late 2023. In 2024, he was called up again to serve for a period of months. He has since returned back to work. As a result of Nadav’s absence, his workload was handled by our US based geologist Lee Russell. We have been able to keep up with the geological workload without any issues.
Our operations in Israel take place at the wellsite in north central Israel, away from the primary location of the war in southern Israel. Our drilling rig, pad site, employees and service providers were safe throughout 2024 and through the date of this report in May 2025.
Throughout 2024, there were daily battles occurring in the Gaza Strip. Israel was largely successful in winning the battles, including taking operational control of nearly all areas of Gaza and killing many top leaders of Hamas.
On or about January 19, 2025, Israel and Hamas agreed to a ceasefire. After that date, various agreements have been reached between Israel and Hamas regarding the release of Israeli hostages and the simultaneous release of Hamas prisoners while maintaining a ceasefire. However, hostilities recently began again pending release of the remaining Israeli hostages.
Israel-Hezbollah War
Throughout the first 4-6 months of 2024, the IDF (“Israeli Defense Forces”) and Hezbollah (a terrorist organization based in Lebanon) exchanged near daily missile and rocket fire at Israel’s northern border. During Q3 2024, the IDF carried out multiple strikes against the Hezbollah leadership and was very successful.
On October 1, 2024, Israel invaded Lebanon to attack Hezbollah directly. Israel and the IDF were successful including killing much of the top leadership of Hezbollah.
On November 27, 2024, Israel and Hezbollah signed a ceasefire agreement.
So far in 2025, the ceasefire is holding with only occasional minor rocket fire being exchanged.
Russia – Ukraine War
Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the year ended December 31, 2024, and the quarter ended March 31, 2025, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company’s, and actions that may be taken by governmental authorities related to the war.
Critical Accounting Policies
Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenues and expense during the reporting period.
We have identified the accounting principles which we believe are most critical to the reported financial status by considering accounting policies that involve the most complex of subjective decisions or assessment.
Impairment of Oil and Gas Properties
We follow the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.
All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in income from continuing operations before income taxes, and the adjusted carrying amount of the unproved properties is amortized on the unit-of-production method.
Our oil and gas properties represent an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. A further impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.
Abandonment of properties is accounted for as adjustments to capitalized costs. The net capitalized costs are subject to a “ceiling test” which limits such costs to the aggregate of the estimated present value of future net revenues from proved reserves discounted at ten percent based on current economic and operating conditions, plus the lower of cost or fair market value of unproved properties. The recoverability of amounts capitalized for oil and gas properties is dependent upon the identification of economically recoverable reserves, together with obtaining the necessary financing to exploit such reserves and the achievement of profitable operations.
During the three months ended March 31, 2025, and 2024, respectively, the Company recorded $nil and $nil in post-impairment charges.
The total net book value of our unproved oil and gas properties under the full cost method is $22,449,000 and $21,682,000 at March 31, 2025 and at December 31, 2024, respectively.
Asset Retirement Obligation
We record a liability for asset retirement obligation at fair value in the period in which it is incurred and a corresponding increase in the carrying amount of the related long-lived assets.
Fair Value Considerations
We follow ASC 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.
There are three levels of inputs to fair value measurements - Level 1, meaning the use of quoted prices for identical instruments in active markets; Level 2, meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3, meaning the use of unobservable inputs. We use Level 1 inputs for fair value measurements whenever there is an active market, with actual quotes, market prices, and observable inputs on the measurement date. We use Level 2 inputs for fair value measurements whenever there are quoted prices for similar securities in an active market or quoted prices for identical securities in an inactive market. We use observable market data whenever available.
RESULTS OF OPERATIONS
| For the three months ended |
||||||||
| March 31, |
||||||||
| 2025 |
2024 |
|||||||
| (US $ in thousands) |
||||||||
| Operating costs and expenses: |
||||||||
| General and administrative expenses |
1,101 | 1,175 | ||||||
| Other |
599 | 599 | ||||||
| Subtotal Operating costs and expenses |
1,700 | 1,774 | ||||||
| Other expense (income), net |
(25 | ) | (12 | ) | ||||
| Net loss |
1,675 | 1,762 | ||||||
Revenue. We currently have no revenue generating operations.
Operating costs and expenses. Operating costs and expenses for the three months ended March 31, 2025 were $1,700,000 compared to $1,774,000 for the three months ended March 31, 2024. Operating costs and expenses for the three months ended March 31, 2025 were $74,000 (4.2%) lower compared to the three months ended March 31, 2024.
General and administrative expenses. General and administrative expenses (“G&A expenses”) for the three months ended March 31, 2025 were $1,101,000 compared to $1,175,000 for the three months ended March 31, 2024. This expense grouping includes salaries, benefits, stock option expenses and professional fees. G&A expenses were lower by $74,000, or 6.3%, during the most recent quarter versus the prior year primarily due to lower expenses associated with stock option grants.
Other expense. Other expenses during the three months ended March 31, 2025 were $599,000 compared to $599,000 for the three months ended March 31, 2024. Other general and administrative expenses are comprised of non-compensation and non-professional expenses incurred.
Other (income), net. Other (income) during the three months ended March 31, 2025 were ($25,000) compared to ($12,000) for the three months ended March 31, 2024. The expenses in this category are comprised of foreign currency exchange costs, primarily the New Israeli Shekel (NIS) to the US dollar, and the financial expenses/income.
Net Loss. Net loss for the three months ended March 31, 2025 were $1,675,000 compared to $1,762,000 for the three months ended March 31, 2024.
Liquidity and Capital Resources
Liquidity is a measure of a company’s ability to meet potential cash requirements. As discussed above, we have historically met our capital requirements through the issuance of common stock as well as proceeds from the exercise of warrants and options to purchase common shares. As disclosed on our Balance Sheet, the company has 1,200,000,000 shares of authorized common stock and 1,027,404,758 shares issued as of March 31, 2025. We are planning to increase our authorized shares during the next proxy season in 2025.
Our ability to continue as a going concern is dependent upon obtaining the necessary financing to complete further exploration and development activities and generate profitable operations from our oil and natural gas interests in the future. Our current operations are dependent upon the adequacy of our current assets to meet our current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, our ability to continue as a going concern will be impaired. Our financial statements for the three months ended March 31, 2025 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We have incurred a history of operating losses and negative cash flows from operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued.
At March 31, 2025, we had approximately $5,058,000 in cash and cash equivalents compared to $2,272,000 at December 31, 2024, which does not include any restricted funds. Our working capital (current assets minus current liabilities) was $5,392,000 at March 31, 2025 and $1,702,000 at December 31, 2024.
As of March 31, 2025, we provided bank guarantees to various governmental bodies (approximately $971,000) and others (approximately $91,000) in respect of our drilling operation in the aggregate amount of approximately $1,062,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as cash and cash equivalents - restricted.
During the three months ended March 31, 2025, cash used in operating activities totaled $2,457,000. Cash provided by financing activities during the three months ended March 31, 2025 was $6,041,000 and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $798,000 for the three months ended March 31, 2025.
During the three months ended March 31, 2024, cash used in operating activities totaled $2,003,000. Cash provided by financing activities during the three months ended March 31, 2024 was $2,838,000 and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $324,000 for the three months ended March 31, 2024.
Accounting standards require management to evaluate our ability to continue as a going concern for a period of one year subsequent to the date of the filing of this Form 10-Q. We expect to incur additional significant expenditures to further our exploration and development programs. While we raised approximately $6,816,000 during the period April 1, 2025 through May 7, 2025, which includes collection of the $212,000 stock subscription receivable at March 31, 2025, we will need to raise additional funds in order to continue our exploration and development activities in our license area. Additionally, we estimate that, when we are not actively drilling a well, our expenditures are approximately $600,000 per month excluding exploratory operational activities. However, when we are actively drilling a well, we estimate an additional minimum expenditure of approximately $2,500,000 per month. The above estimates are subject to change. Subject to the qualifications specified below, management believes that our existing cash balance, coupled with anticipated proceeds under the DSPP, will be sufficient to finance our plan of operations through December 2025.
During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.
Similar uncertainties are posed by the Israel-Hamas war, as well as the Israel-Hezbollah war. The duration of both wars and its impact on the region and world is not fully known at this point in time.
No assurance can be provided that we will be able to raise the needed operating capital.
Even if we raise the needed funds, there are factors that can nevertheless adversely impact our ability to fund our operating needs, including (without limitation), the potential impact of the Israel-Hamas war, the Israel-Hezbollah war, the potential actions of other hostile parties in the region, unexpected or unforeseen cost overruns in exploratory work in existing license areas, the costs associated with extended delays in undertaking the required exploratory work, and plugging and abandonment activities which is typical of what we have experienced in the past.
The financial information contained in these consolidated condensed financial statements has been prepared on a basis that assumes that we will continue as a going concern for one year from the date the financials were issued, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. This financial information and these consolidated condensed financial statements do not include any adjustments that may result from the outcome of this uncertainty.
Off-Balance Sheet Arrangements
We do not currently use any off-balance sheet arrangements to enhance our liquidity or capital resource position, or for any other purpose.
Recently Issued Accounting Pronouncements
In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. The ASU improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments will be applied retrospectively to all prior periods presented in the financial statements. Zion adopted this ASU effective January 1, 2023. The adoption of this ASU did not have any impact on its consolidated financial statements.
Other Recent Accounting Pronouncements
The Company does not believe that the adoption of any recently issued accounting pronouncements in 2025 had a significant impact on our financial position, results of operations, or cash flow.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.
Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2025 through March 31, 2025, the USD has fluctuated by approximately 0.6% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2024 through December 31, 2024, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.
Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At March 31, 2025 we had cash, cash equivalents, and restricted cash of approximately $6,122,000. The weighted average annual interest rate related to our cash and cash equivalents for the three months ended March 31, 2025, exclusive of funds at US banks that earn no interest, was approximately 2.8%.
The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.
ITEM 4. CONTROLS AND PROCEDURES
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms. As of March 31, 2025, our chief executive officer and our chief financial officer conducted an evaluation of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and our chief financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2025.
Changes in Internal Control over Financial Reporting
There were no changes in internal controls over financial reporting that occurred during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
Litigation
From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes.
The Company is not subject to any litigation at the present time.
During the quarter ended March 31, 2025, there were no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2024.
ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
None.
| 31.1 |
||
| 31.2 |
||
| 32.1 |
||
| 32.2 |
||
| 101.INS |
Inline XBRL Instance Document |
|
| 101.SCH |
Inline XBRL Taxonomy Extension Schema Document |
|
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
| 101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document |
|
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
| 104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ZION OIL & GAS, INC. |
||||
| (Registrant) |
||||
| By: |
/s/ Robert W.A. Dunn |
By: |
/s/ Michael B. Croswell Jr. |
|
| Robert W. A. Dunn |
Michael B. Croswell Jr. |
|||
| Chief Executive Officer |
Chief Financial Officer |
|||
| (Principal Executive Officer) |
(Principal Financial and Accounting Officer) |
|||
| Date: |
May 8, 2025 |
Date: |
May 8, 2025 |
|